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Abstract
Background: A body mass index (BMI) ≥30 kg/m2 and a waist circumference (WC) ≥80 cm in women (WCF) or ≥90
cm in men (WCM) are reference cardiometabolic risk markers (CMM) for Mexicans adults. However, their reliability to
predict other CMM (index tests) in young Mexicans has not been studied in depth.
Methods: A cross-sectional descriptive study evaluating several anthropometric, physiological and biochemical CMM
from 295 young Mexicans was performed. Sensitivity (Se), specificity (Sp) and Youden’s index (J) of reference BMI/WC
cutoffs toward other CMM (n = 14) were obtained and their most reliable cutoffs were further calculated at Jmax.
Results: Prevalence, incidence and magnitude of most CMM increased along the BMI range (p < 0.01). BMI explained
81 % of WC’s variance [Se (97 %), Sp (71 %), J (68 %), Jmax (86 %), BMI = 30 kg/m2] and 4–50 % of other CMM. The five
most prevalent (≥71 %) CMM in obese subjects were high WC, low HDL-C, and three insulin-related CMM [Fasting insulin,
HOMA-IR, and QUICKI]. For a BMI = 30 kg/m2, J ranged from 16 % (HDL-C/LDL-C) to 68 % (WC), being moderately reliable
(Jmax = 61–67) to predict high uric acid (UA), metabolic syndrome (MetS) and the hypertriglyceridemic-waist phenotype
(HTGW). Corrected WCM/WCF were moderate-highly reliable (Jmax = 66–90) to predict HTGW, MetS, fasting glucose and
UA. Most CMM were moderate-highly predicted at 27 ± 3 kg/m2 (CI 95 %, 25–28), 85 ± 5 cm (CI 95 %, 82–88)
and 81 ± 6cm (CI 95 %, 75–87), for BMI, WCM and WCF, respectively.
Conclusion: BMI and WC are good predictors of several CMM in the studied population, although at different
cutoffs than current reference values.
Keywords: Metabolic syndrome, Cardiometabolic risk, Body mass index, Waist circumference, Central obesity,
Youden’s index
Background
Mexico’s epidemiological transition is advanced with a
major burden coming from non-communicable chronic
diseases. The fast urbanization, industrial development,
technocratization and the apparent country’s prosperity,
have improved the Mexicans lifestyle but simultaneously
has diminished its health [1]. The rising adult mortality
from cardiometabolic diseases (CMD), such as type 2 dia-
betes mellitus (T2DM) and hypertension (HTN) [2], a sud-
den (2014–2016) increase in their prevalence (8–12 %) and
an unstoppable increment in treatment annual costs (US$/
patient): 485 to 622 (HTN), 699 to 748 (T2DM) [3] are all
indicative of the diminishing health state of the people. As
if this were not enough, health inequities by region and
population segments are still evident despite the govern-
ment’s efforts to reduce them [4–6]. Therefore, it is in-
creasingly urgent the timely diagnosis of CMD, by applying
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highly sensitive, reliable and economical methods, in order
to reduce their burden for public health.
Obesity [body mass index (BMI) ≥30 kg/m2] and central
adiposity [waist circumference (WC) ≥80 cm women
(WCF), ≥90 cm men (WCM)] are prodromal conditions
for many CMD [7, 8], including T2DM, metabolic syn-
drome (MetS) and cardiovascular disease (CVD). BMI and
WC are more accurate than measured body fat by dual X-
ray absorptiometry (DEXA), being WC a better predictor
of these CMD and other inflammatory diseases [9, 10].
However, there are other CMD risk markers (CMM):
HTN (≥130/≥85 mmHg), dyslipidemias [triacylglycerides
(TAG ≥150 mg/dl), total cholesterol (TC ≥200 mg/dl),
low-density lipoprotein cholesterol (LDL-C ≥100 mg/dl),
and high-density lipoprotein cholesterol (HDL-C <50 mg/
dl women, <40 mg/dl men)] and high fasting glucose (FG
≥100 mg/dl) and insulin (FI ≤14.0 μU/ml women, ≤11.0
μU/ml men [11, 12]). Clustered CMM includes the
hypertriglyceridemic-waist phenotype (HTGW), athero-
genic index (TC/HDL-C, >3.6 women, >4.3 men), TAG/
HDL-C (>2.4 women, >2.9 men), insulin resistance (IR:
HOMA-IR >2.9 women, > 2.3 men), and quantitative in-
sulin sensitivity check index (QUICKI ≤0.33) [8, 13–15].
Also, since therapeutic lifestyle changes remain an essen-
tial modality in the clinical management of CMD, other
health determinants including age (≥55 y woman, ≥45 y
men), family history of CMD, smoking, sedentary lifestyle
and high saturated fat intake, are also considered risk fac-
tors [16, 17].
International (e.g. WHO or NHBLI) and Mexican cut-
offs for each CMM, including BMI and WC, have been
established so far. However, most of them are influenced
by ethnicity, gender, age and the presence of co-
morbidities [18]. That is why, their sensitivity (Se) and
specificity (Sp) changes from one population/region/
country to another [19, 20]. As in case of age, according
to the 2006 National Health & Nutrition Survey [21]
~50 % of Mexican adults (≥20 y) had at least one altered
CMM, 36.8 % have MetS [22], and the most common
CMM were low HDL-C (76.8 %), high WC (73.6 %) and
the triad HDL-C/HTN/WC (20 %) while high TAG
(30.9 %) and the triad TAG/HTN/FG (0.5 %) ranked the
lowest prevalent. According to this survey, age and loca-
tion (urban/rural) have an impact on MetS prevalence but
gender and socioeconomic status do not. However, ~72 %
of young Mexicans (17–25 y) have at least one altered
CMM, 13.4 % have MetS, and the most prevalent CMM
were low HDL-C (41.8 %) and high WC (38.3 %) and
TAG (18.5 %), and gender, age and even region modify
MetS prevalence [8, 14, 19].
Although international standardization of CMM cutoffs
allows the timely comparison and monitoring of health
policies worldwide, the use of age-specific cutoffs to evalu-
ate intervention programs in Mexico should be carefully
selected [23–25]. The aim of this study was to evaluate
the predictive value of BMI and WC toward other CMM
abnormalities in young Mexicans, using the Youden’s
index (J) for improving their specific cutoffs to achieve the
highest Se and Sp (Jmax) [26, 27].
Methods
Study design & population
A cross-sectional descriptive study with a randomized
sampling and multivariate (in BMI) and bivariate (in WC)
stratification was performed. 2683 students (18.7 ± 2.7 y;
age range 17–38) admitted in August 2014 by the Autono-
mous University of Ciudad Juarez (UACJ), were consid-
ered the initial universe. UACJ matriculates 3900 ± 500
students every six months, all considered participants in
the “Healthy University” project, a comprehensive pro-
gram that fosters academic performance by improving
health and quality of life of students as well as their em-
powerment as public health promoters [28]. The sample
size was considered large enough (11 %) to detect (5 %
precision) the lowest CMM (high FG = 2 %) found in a
preceding study [8] with a larger population (22 ± 5 y,
n = 8144, 49 % women). However, as the purpose of
the study was to validate BMI and WC as independ-
ent predictors of other CMM, a randomized sampling
(based on the automatic selection of cases by school
enrollment numbers) with a replacement strategy was
performed in order to obtain proportional samples (50 %
women/ 50 % men) within 4 BMI groups (n = 294, n =
71–77 per group) with the following demographics: 50 %
female, 19 ± 2 y, medium-high socioeconomic level. All
students perceived themselves as healthy and no CMD
was diagnosed by the assigned and trained physician.
Data collection procedure
A) Anthropometry: Height was determined to the nearest
0.1cm using a mobile stadiometer (SECA 208, Birming-
ham, UK), with the subject’s head in the Frankfurt plane.
Body weight was determined to the nearest 100g using a
digital scale (Tanita 682, Illinois, USA). Body mass index
was then calculated [BMI = weight (kg) /height (m)2].
WC was measured to the nearest 0.1cm midway be-
tween the top of the ileac crest and the bottom of the
rib cage, perpendicular to the trunk long axis, using a
non-stretch measuring tape. These procedures were per-
formed as recommended by the International Society for
the Advancement of Kinanthropometry (ISAK) and the
WHO STEPS protocol. B) Blood pressure (BP): It was
measured with a manual aneroid sphygmomanometer
(Model DS44, Welch-Allyn) to the nearest 1 mmHg in a
seated position with the dominant arm resting and the
palm facing upwards. The first Korotkoff sound marked
the systolic (SBP) and the fifth the diastolic (DBP) blood
pressure. Average readings (n = 3, every 5 min) were
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recorded at least 15 min after the participant arrival to
the laboratory. C) Biochemistry: Students came to the
University laboratory facilities between 7 and 10 AM
after overnight fasting. Venous (antecubital) blood sam-
ples were obtained in suitable Vacutainer® tubes by
trained biochemists responsible for sample collection,
and all analyses were performed by Grupo Diagnóstico
Médico PROA, S.A. de C.V., a Mexican internationally
certified and accredited reference laboratory. Blood sam-
ples were centrifuged and the supernatant was recovered
and used to measure the following biochemical parame-
ters: FG, Uric acid (UA), TAG, CT, and HDL-C (mg/dL)
by automatized enzymatic-colorimetric methods with an
overall intra- and inter-assay coefficients of variation
(CV) of <5 % and insulin (μU/ml) by ELISA; sensitivity
was 0.5 μU/mL, and CV <5 %. Non HDL-C, LDL-C
[29], HOMA-IR [16] and QUICKI [13], were then calcu-
lated with the following equations:
Non HDL−C ¼ TC − HDL−Cð Þ ð1Þ
LDL−C ¼ TC – HDL‐Cð Þ – TAG=5 ð2Þ
HOMA−IR ¼ FI  FG=405 ð3Þ
QUICKI ¼ 1= log FIð Þ þ log FGð Þ½  ð4Þ
Operational definitions
Students were classified at risk of CMD if they had at
least one altered CMM, or as healthy if they had none of
them. MetS was defined according to the consensus def-
inition (IDF/NHLBI/AHA/WHF/IAS/IASO) [30] if they
met at least 3 of the following traits or conditions: WC
(WCF ≥80 cm, WCM ≥90 cm), TAG (≥150 mg/dl),
HDL-C (<50 mg/dl women, <40 mg/dl men), HTN
(≥130/≥85 mmHg) and FG (≥100mg/dl). Hyperuricemia
(UA) was defined here as UA (mg/dl) >7.0 women, >8.0
men [31].
Statistical analysis
All statistical analyses were performed with SPSS statis-
tical software package version 22.0 (SPSS Inc., Chicago,
IL, USA). All anthropometric, physiological and bio-
chemical parameters were evaluated in stratified groups:
A) By BMI [n = 71–77 each: <18.5 (underweight), 18.5–
24.9 (normal), 25.0–29.9 (overweight) and ≥30.0 kg/m2
(obese)], B) In two (normal & high) WCF/WCM groups,
Goodness-of-fit (R2) between BMI and other CMM was
performed, adjusting data to the best regression curve
possible (linear, quadratic, cubic, exponential or power).
The reliability of reference standard BMI (25 and 30
kg/m2), WCF ≥80 cm and WCM ≥90 cm cutoffs as inde-
pendent predictors of other CMM abnormalities, was ana-
lyzed by their sensitivity (Se, low false negatives) and
specificity (Sp, low false positives) using crosstabs [14],
receiver operating characteristic (ROC) curves, and You-
den’s Index (J) [26]. J (Eq. 5) is defined at all points of a
ROC-curve and its maximum value (Jmax = highest Se
and Sp) is used as a criterion for selecting the optimum or
most reliable cutoff (Fig. 1).
J ¼ Sensitivity Se; %ð Þ
þ Specificity Sp; %ð Þ – 100 ð5Þ
Results
CMM values (mean ± SD) increased across BMI categories
(p ≤ 0.01, Table 1). WC, the 1st and 4th most prevalent
Fig. 1 Jmax-corrected sensitivity & specificity of BMI and WC to predict
other CMM. Legend: cardio-metabolic risk marker (CMM), see other
abbreviations in text
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CMM in obese and overweight subjects respectively
(Table 2), showed the strongest linear (R2 = 0.69) or cubic
(R2 = 0.81) relationship with BMI. FG (1–5 %), TC and UA
(3–20 %) were the less prevalent CMM across BMI cat-
egories. Quadratic regression did not improve the linear
trend between BMI and most CMM, while power
(Log-Log) regression improved that of HOMA-IR,
TC/HDL-C and TG/HDL-C. Except for WC (81 %), BMI
explained 4 to 50 % of the associated variance to all other
CMM, regardless of the goodness-of-fit model.
Both, prevalence (Table 2) and incidence (Table 3) of ab-
normal CMM increased across BMI categories (p ≤ 0.01).
However, increments (Δ) in lipid-related CMM, UA, FG
and HTGW were low between normal to overweight
(ΔN-OW). However, except for TC, HDL-C, LDL-C, HTA
and FG (+2–11 %), huge increments (+16–53 %) in all
other CMM were observed from overweight to obesity
(ΔOW-OB). The five most prevalent (≥71 %) CMM in obese
subjects were high WC, FI, HOMA-IR, QUICKI and
HDL-C while the less prevalent was FG (5 %). An add-
itional 21, 26 and 40 % subjects with HTGW, MetS and
IR, respectively, increased from overweight to obesity.
Also, 74–75 % under- or normal weight subjects had 1–2
altered CMM, 58 % overweight subjects had 3–6 altered
CMM, and 54 % obese subjects had 6–8 altered CMM.
Reliability [sensitivity (Se, low false negatives) + specifi-
city (Sp, low false positives)] of both BMI cutoffs (25 and
30 kg/m2) to predict WC changes did not vary much:
[Youden’s Index (J), 68 to 74] reaching 97 % (Se) and 71 %
(Sp) in obese subjects (Table 4). However, changing the
BMI from 25 to 30 kg/m2 decreased Se but increased Sp
to the same extent (~24 % in average) when predicting
other CMM. With a BMI = 30 kg/m2, the lowest and high-
est Se was observed for HDL-C and LDL-C (33–34 %)
and UA and HTGW (79 %), respectively while its Sp was
for WC and FG (71–75 %) and HOMA-IR/FI/QUICKI
(90–91 %). WCF showed practically the same prediction
Table 1 Cardio-metabolic risk markers (CMM) stratified by BMI (kg/m2) categories
CMMa <18.5 18.5 to < 24.9 25.0 to 29.9 ≥ 30.0 R2
Linear Otherb Typeb
BMI 17.4 ± 0.8 21.8 ± 1.8 26.9 ± 1.4 34.9 ± 5.3
WC 62.5 ± 4.8 70.7 ± 6.3 82.0 ± 7.5 96.5 ± 10.7 0.69 0.81 B
SBP 105.0 ± 11.0 110.0 ± 14.0 117.0 ± 11.0 120.0 ± 16.0 0.13 0.18 A
DBP 69.0 ± 9.0 72.0 ± 9.0 76.0 ± 11.0 79.0 ± 11.0 0.11 0.14 A
HDL-C 46.9 ± 8.7 45.2 ± 9.1 42.4 ± 8.9 37.9 ± 11.3 0.08 0.17 B
LDL-C 80.4 ± 21.1 98.2 ± 28.3 98.5 ± 25.2 111.2 ± 37.9 0.10 0.12 A
Non HDL-C 95.9 ± 22.8 115.3 ± 30.9 116.1 ± 29.4 138.0 ± 43.2 0.14 0.17 B
TC 142.8 ± 25.6 160.5 ± 31.1 158.6 ± 28.2 175.9 ± 41.5 0.09 0.11 D
TC/HDL-C 3.1 ± 0.6 3.7 ± 1.0 3.9 ± 1.0 5.1 ± 2.3 0.16 0.22 D
TAG 77.0 ± 24.0 87.5 ± 42.9 98.2 ± 37.8 144.9 ± 96.0 0.11 0.14 A
TAG/HDL-C 1.7 ± 0.7 2.1 ± 1.4 2.5 ± 1.3 4.9 ± 6.1 0.07 0.17 D
FG 77.1 ± 9.0 77.4 ± 8.1 81.2 ± 10.7 82.0 ± 12.2 0.04 0.50 A
FI 9.0 ± 7.7 10.0 ± 5.6 13.9 ± 12.3 20.8 ± 11.6 0.17 0.27 C
HOMA-IR 1.8 ± 1.6 2.0 ± 1.2 2.9 ± 2.9 4.3 ± 2.6 0.14 0.25 D
QUICKI 0.37 ± 0.03 0.36 ± .03 0.34 ± 0.03 0.32 ± 0.02 0.23 0.26 A
UA 4.4 ± 1.0 4.9 ± 1.0 5.3 ± 1.3 6.0 ± 1.5 0.12 0.20 B
Values are shown as mean ± SD. R2 at p < 0.01; aSee abbreviations and units in text; bQuadratic (A), cubic (B), exponential (C), power (D) regression
Table 2 Prevalence (%) of altered CMM by BMI (kg/m2)
category
CMMa <18.5 18.5 to <24.9 25.0 to 29.9 ≥30.0 ΔN-OW ΔOW-OB
WC 0 1 39 92 38 53
HTA 7 8 28 39 20 11
HDL-C (↓) 44 42 66 71 24 5
LDL-C 13 47 41 58 6 11
TC 3 5 9 20 4 11
TAG 1 7 13 31 6 18
TAG/HDL-C 7 21 28 47 7 19
FG 1 1 3 5 2 2
FI (↑) 16 18 43 81 25 38
HOMA-IR 13 17 35 75 18 40
QUICKI (↓) 10 15 31 75 16 44
HTGW 0 0 9 30 9 21
UA 0 1 4 20 3 16
MetS 0 0 16 42 16 26
P-trend <0.01; aSee abbreviations and units in text; otherwise indicated, a
higher CMM value (than cut off point) was considered altered. Increment (Δ)
from normal-overweight (N-OW), from overweight-obesity (OW-OB)
Wall-Medrano et al. BMC Public Health  (2016) 16:236 Page 4 of 9
power like WCM (same Se and Sp) toward the same
CMM: Lowest (HDL-C and LDL-C) and highest (UA,
HTGW, MetS) Se, lowest (TC) and highest (FI, HOMA-
IR, QUICKI) Sp. J ranged from 16 % (HDL-C and LDL-C)
to 68 % (WC) for BMI (30 kg/m2), from 14 % (LDL-C) to
74 % (MetS) for WCF and from 23 % (LDL-C) to 78 %
(HTGW) for WCM.
When plotting the most reliable Se & Sp (that is, those
obtained at Jmax), it was possible to graphically identify
the best predicted CMM by BMI (up), WCM (center)
and WCF (down), as the closest CMM located at the
upper right corner of each graph (Fig. 1). As expected,
BMI was a strong predictor of WC (Jmax = 68–74 %)
and to a lesser extent of HTGW, UA and MetS (Jmax =
48–59 %). WCM predicted in strong manner HTGW,
MetS, UA and QUICKI (Jmax = 50–78 %) while WCF
predicted MetS, HTGW, and UA (Jmax = 68–74 %).
The less reliable prediction at Jmax was as follows:
HDL-C & LDL-C, (Jmax = 14–34 %; BMI/WCF/
WCM), TC (Jmax = 31–38 %, BMI/WCM/WCF), and
FG (Jmax = 25–43 %, BMI/WCF/BMI). Lastly, specific
BMI and WC cutoffs to predict other CMM with the
highest reliability (at Jmax) are depicted in Fig. 1. Lastly,
standard cutoffs for Mexican adults (bold) differed from
those obtained at Jmax [specific (grey squares), CI95 %
(↔)]: Distribution of most CMM was moderate-highly re-
liable at 27 ± 3 kg/m2 (CI 95 %, 25–28), 85 ± 5 cm (CI
95 %, 82–88) and 81 ± 6cm (CI 95 %, 75–87), for BMI,
WCM and WCF, respectively (Fig. 2).
Discussion
Overweight and obesity in young Mexicans has reached
epidemic proportions. According to the 2012 National
Health & Nutrition Survey [32], four (17–19 y) and five
(20–29 y) out of ten young Mexicans have a BMI ≥25 kg/
m2, most of them bearing a morbid WC. BMI and WC
have increased overtime in Mexicans [33] as a conse-
quence of lifestyle changes (e.g. low physical activity and
unhealthy dietary habits); however, as compared to BMI,
WC has increased disproportionately from 1999 to 2012,
particularly in young (20–29 y) woman (WCF: +6.6 cm, p
< 0.0001) [34]. The National Agreement for Nutritional
Health (ANSA) and other public policies aimed to prevent
and control obesity, should be strengthened and improved
urgently since there is no evidence to infer that this trend
will decrease in the near future [1, 23, 33], particularly if
intervention & surveillance programs are not properly de-
signed, implemented and evaluated. About this, BMI and
WC cutoffs established by international organizations (e.g.
WHO or NHBLI) are often used to evaluate not only
their secular trends but also as surrogate measures to
evaluate CMD risk. However, BMI and WC cutoffs are
influenced by ethnicity, gender, age and the presence of
co-morbidities [9, 18, 35, 36], so age-specific cutoffs to
evaluate intervention programs in Mexico should be
carefully selected [23–25].
A BMI ≥25 kg/m2 is associated with greater odds of
CMM abnormalities, MetS, IR, HTN, and T2DM [2, 11,
12]. That is why many of studies published in the last ten
years have been focused not only on CMM’s epidemiology
but also on the specific clustering patterns of BMI with
other CMM [35, 36]. However, very few have explored the
prevalence or incidence of CMM along the BMI range,
particularly in Mexican youth [19]. This study shows that,
with few exemptions (e.g. FG), the magnitude, prevalence
and incidence of any CMM increase across BMI categor-
ies (p ≤ 0.01), with huge increments between 25 and 30
Table 3 Incidence (%) of altered CMM by BMI (kg/m2) category
# <18.5 18.5 to <24.9 25.0 to 29.9 ≥30.0
1 35.2 26.3 7 3.9
2 39.4 28.9 14.1 5.2
3 9.9 18.4 26.8 5.2
4 11.3 9.2 9.9 7.8
5 1.4 5.3 5.6 9.1
6 1.4 3.9 15.5 22.1
7 1.4 5.3 8.5 16.9
8 2.7 8.5 15.3
9 4.1 6.7
≥10 7.8
Number of altered CMM (#)
Table 4 Se, Sp and Youden’s Index (J) of BMI & WC to detect
other CMM abnormalities
CMMa,b BMI (kg/m2) WC(cm)
25 30 WCF WCM
Se Sp J Se Sp J Se Sp J Se Sp J
WC 99 75 74 97 71 68
HTA 82 58 40 49 80 29 71 69 40 57 78 35
HDL-C (↓) 62 65 27 33 83 16 43 81 24 52 82 34
LDL-C 62 58 20 34 82 16 45 69 14 45 78 23
TC 78 53 31 56 77 33 58 67 25 67 71 38
TAG 85 55 40 62 79 41 90 68 58 69 76 45
TAG/HDL-C 74 59 33 50 83 33 53 71 24 64 80 44
FG 75 51 26 50 75 25 75 64 39 75 68 43
FI (↑) 79 69 48 53 91 44 64 80 44 58 88 46
HOMA-IR 79 65 44 55 90 45 69 79 48 58 85 43
QUICKI (↓) 82 65 47 59 90 49 67 79 46 65 85 50
HTGW 100 55 55 79 80 59 100 69 69 100 78 78
UA 95 53 48 79 78 57 100 68 68 77 73 50
MetS 100 58 58 74 82 56 100 74 74 93 82 75
aOtherwise specified, a higher CMM value (than cut-off point) was considered
at risk for CMD, sensitivity (Se, %), specificity (Sp, %). J = Se (%) + Sp (%) – 100
[25], bSee text for abbreviations and units
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kg/m2. This behavior is supported by the fact that, in
many cases, the mathematical relationship between BMI
and each CMM improved with a nonlinear goodness-of-
fit. The five most prevalent (≥71 %) CMM in obese sub-
jects were high WC, HDL-C and three insulin-related
CMM. Also, 16 % (overweighed) and 42 % (obese) sub-
jects presented ≥3 MetS traits, and an additional 21, 26
and 40 % subjects with CMM-clustered phenotypes
(HTGW, MetS and IR, respectively) were added from
overweight to obesity. Based on these results, BMI is still
valuable for the primary screening of CMD in school
health programs such as Healthy University [28]. Many
cross-sectional studies also support the usefulness of BMI
for CMD screening [35–37], but also support the idea that
BMI is an even better predictor if it is co-assayed or clus-
tered with other anthropometric [e.g. WC, fat (FMI) and
lean body mass index (LBMI)] or biochemical (e.g. such as
TAG or HDL-C) CMM, either as simple risk scores (ra-
tios) or in prospective equations. In our case, the study of
novel associations between BMI (or WC) with the ob-
served low prevalent (e.g. FG) or mild-BMI sensitive (e.g.
TC, HDL-C) CMM, deserves further investigations.
However, despite the fact that 74–75 % subjects with a
BMI <25 kg/m2 only had 1 or 2 altered CMM, ~46 % lean
(18.5 to < 24.9 kg/m2) subjects were dyslipidemic (↑LDL-
C, TAG/HDL-C; ↓HDL-C) while ~17 % were insulin-
resistant (↑FI, ↑HOMA-IR). This “silent” phenomenon
has several causes including the Mexican’s genetic predis-
position to dyslipidemias [38] and T2DM [39], or the
higher prevalence of snacking [40] and intake of junk food
[41] that is quite popular in this population segment.
However, these findings also indicate that weight gain it-
self do not impose a concurrent CMD risk in younger
people from northern Mexico. In the OPUS PRIME study
[35] the relative frequency of nine phenotypes [36 % lean,
43 % overweighed, and 21 % obese Mexican adults clus-
tered in three CMM profiles (MetS traits): normo-
metabolic (none), intermediate (1–2) and dysmetabolic
(≥3)] was evaluated; the study showed that only 27 % lean
subjects were normo-metabolic, while only 37 % of obese
individuals were dysmetabolic. Murguía-Romero et al.
[19] also reported from a national representative study
with 3176 young (17–24 y) that all BMI strata included a
MetS prevalence greater than zero (5.7 % lean, 21.8 %
overweighed, and 48.6 % obese), implying once again that
weight gain is not a mandatory factor for MetS.
WC is a crude estimate of abdominal fat accumulation
and its measurement provides additional information on
CMD risk at any given BMI value. As compared to BMI,
WC is a better predictor of certain dysmetabolic processes
such as inflammation, dyslipidemias and non-insulin
dependent diabetes mellitus [8–11, 20]. Here, conventional
WC cutoffs for Mexican adults (WCM/WCF) were moder-
ate reliable (J = 69–78) to predict MetS and HTGW (both
including a high WC in their definition) and UA in women
(J = 68). In a previous study we have reported the excellent
reliability of HTGW as surrogate measure for MetS in
young Mexicans [8], since it is related to a higher weight,
BMI, FG, TC, BP and to lower levels of HDL-C, which in
turn are associated to a higher risk for HTN and IR. So,
the binary association implied in HTGW (high TAG, high
WC) normalizes WC to increase its Se and Sp to predict
Fig. 2 CMM distribution along BMI and WC range1. Legend: 1 Jmax –corrected cutoffs; Conventional BMI and WC (WCM/WCF) cutoff values
(bold), Jmax-derived cutoff values to predict individual (grey square) and CI 95 % (↔) CMM; cardio-metabolic risk markers (CMM): WC (1), HTA (2),
HDL-C (3), LDL-C (4), TC (5), TAG (6), TAG/HDL-C (7), FG (8), FI (9), HOMA-IR (10), QUICKI (11), HTGW (12), UA (13), MetS (14)
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other CMM. Since young overweighed and obese in-
dividuals with a lower fat mass are more prone to IR
than sex- and BMI-matched adults [42], the specific
relationship between WC and truncal body fat distri-
bution should be evaluated in future studies. Also,
hyperuricemia (UA) is an independent factor associ-
ated with MetS and hypertrigliceridemia [31], HTA,
IR, fatty liver and chronic kidney diseases [43]. To
our knowledge, this is the first report on the associ-
ation of WC with UA in young Mexicans.
However, WC had a very low predictive value toward
lipid related-CMMs (J = 14–58). This could be related to
several metabolic factors such as the high hemodynamics
of cholesterol or the adipocyte’s TAG turnover rate, both
influenced by age and BMI status [44–47], although it
could also be related to the small number of participants
in this study. Nevertheless, WC was the most prevalent
CMM in obese subjects and BMI explained almost all
(81 %) of its associated variance with an excellent reliabil-
ity (Jmax = 86 %), which is consistent with other studies in
young populations [48]. Under the caution that deserves
the comparison due the small population sample, the
prevalence of all CMM and their relationship with WC
and BMI increments largely coincide with other cross-
sectional studies in young Mexicans from central [8, 14]
and northern Mexico [49].
Also, by using a very simple statistical tool (Youden’s
index, J), the most reliable (Jmax) cutoff for BMI, WCM
and WCF to predict other CMM was obtained. Other
studies have also documented the increase in the reli-
ability of several obesity indexes to predict cardiometa-
bolic risk in pediatric populations, when their standard
cutoffs have been corrected at Jmax [37, 50]. Here, most
CMM abnormalities started at a lower BMI (27 ± 3 kg/
m2) and WCM (80 ± 8 cm) but almost same the WCF
(85 ± 5cm) than those proposed by WHO, as previously
found in the 2000 (ENSA) and 2006 (ENSANUT)
Mexican health surveys [25]. Strikingly, certain CMM
reach their highest prediction at BMI and WC cutoffs
out of their CI 95 % range (e.g. UA at WCF = 94 cm).
However, it should be noted that enhancing Se and
Sp to achieve Jmax of any CMM increases its likeli-
hood ratio and odds ratio but do not minimize the
epidemiological value of conventional cutoffs, it just
informs about the possible “lost cases”.
Stregths & limitations
The authors recognize that this study has certain
strengths and limitations. The experimental design and
sampling strategy allowed a reasonable comparison
(same “n”) of the effects of weight gain and central
obesity and several metabolic derangements (CMM) in
a same study, and even when not intended to make in-
ferences about the original universe, the behavior of
this sample was quite similar to our previous study [8].
In addition, the assessment of certain CMM not previ-
ously reported in other studies of the same nature (e.g.
UA), further contributes to the generation of knowledge
in this field. However, its cross-sectional nature does
not allow inferences on the current relationship of any
CMM with a future risk for CMD. In addition, the sam-
ple size could result in no statistical significance for
certain CMM with expected biological deviations.
Nevertheless, our study could be considered as a “pilot”
study, contributing to the design of more extensive
cross-sectional or longitudinal studies.
Conclusions
BMI and WC are good predictors of several CMM in
the studied population, although at different cutoffs than
current reference values. This study enables us to argue
on the importance of the systematic measurement of
WC and BMI, and possibly TAG, to follow the secular
changes in CMD risk among college students.
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